• Skip to primary navigation
  • Skip to main content
  • Skip to primary sidebar
  • Skip to footer
  • Advertise
  • Subscribe

Drug Delivery Business

  • Clinical Trials
  • Research & Development
  • Drug-Device Combinations
  • FDA
  • Pharmaceuticals
  • Policy

Zyno recalls certain infusion pumps due to software issue

June 18, 2025 By Sean Whooley

Zyno Medical infusion pump recall screenshot
[Image from Zyno/FDA]
The FDA classified a recall of certain Zyno Medical infusion pump systems as the most serious kind as a result of a software issue.

This recall involves removing certain devices from use or sale. As the most serious type of recall, it means the device may cause serious injury or death if its use continues.

Zyno Medical told customers that it released certain Z-800, Z-800F, Z-800W and Z-800WF infusion pumps to customers with incorrect software versions. These software versions failed to undergo the required verification and validation testing. As a result, the pumps can experience unexpected performance issues. That includes essential functions and risk measures, like air in line detection, alarm volume and reverse flow prevention.

The company says worst-case scenarios of these failures can result in serious harms like under- or over-delivery of drugs. Air in line can infuse a venous air embolism as well, while it could also lead to the undetected flow reversal of drugs or parenteral fluids. Additionally, lowered keep vein open rates can lead to low flow rates and possibly cause a blood clot to form at the catheter’s distal end.

To date, Zyno reports zero serious injuries or deaths related to the issue.

Zyno told customers to discontinue use of affected devices and follow instructions for its return. The company intends to have a representative contact customers to coordinate device exchanges to remediate the issue.

Filed Under: Drug-Device Combinations, Featured, Recalls, Technology Tagged With: Zyno Medical

IN CASE YOU MISSED IT

  • Insulet hires new chief HR officer from J&J
  • Breakthrough T1D, Mattel debut Barbie doll with type 1 diabetes
  • Medtronic Diabetes names CFO with consumer experience ahead of separation
  • Diabeloop launches insulin delivery algorithm in Germany
  • GlucoModicum has positive data for needle-free CGM

About Sean Whooley

Sean Whooley is an associate editor who mainly produces work for MassDevice, Medical Design & Outsourcing and Drug Delivery Business News. He received a bachelor's degree in multiplatform journalism from the University of Maryland, College Park. You can connect with him on LinkedIn or email him at swhooley@wtwhmedia.com.

Primary Sidebar

“ddb
EXPAND YOUR KNOWLEDGE AND STAY CONNECTED
Get the latest news and trends happening now in drug delivery.

MEDTECH 100 INDEX

Medtech 100 logo
Market Summary > Current Price
The MedTech 100 is a financial index calculated using the BIG100 companies covered in Medical Design and Outsourcing.

Footer

Drug Delivery Business News Logo

MassDevice Medical NETWORK

MassDevice
DeviceTalks
Medical Tubing + Extrusion
Medical Design & Outsourcing
MedTech100 Index
Drug Discovery & Development
Pharmaceutical Processing World
Medical Design Sourcing
R&D World

DRUG DELIVERY BUSINESS NEWS

Subscribe to Drug Delivery’s E-Newsletter
Advertise with us
About
Contact us
Privacy
Listen to our Weekly Podcasts

Copyright © 2025 · WTWH Media LLC and its licensors. All rights reserved.
The material on this site may not be reproduced, distributed, transmitted, cached or otherwise used, except with the prior written permission of WTWH Media.

Privacy Policy | RSS